Ischemic colitis after mesotherapy combined with anti-obesity medications

World Journal of Gastroenterology

Volumn 16, Issue 12, 2010, Pages 1537-1540

  Kim, Jong Bin ^a   Moon, Won ^a   Park, Seun Ja ^a   Park, Moo In ^a   Kim, Kyu Jong ^a   Lee, Jae Nam ^a   Kang, Seong Joo ^a   Jang, Lee La ^a   Chang, Hee Kyung ^a  

^a Kosin University College of Medicine   (South Korea)

Author keywords

Adverse effects; Anti obesity medications; Ischemic colitis; Mesotherapy

Indexed keywords

ADRENALIN; AMINOPHYLLINE; CAFFEINE; CIPROFLOXACIN; EPHEDRINE; FLUOXETINE; LIDOCAINE; METRONIDAZOLE;

ABDOMINAL DISCOMFORT; ABDOMINAL TENDERNESS; ADULT; ARTICLE; CASE REPORT; COLON BIOPSY; COLON HEMORRHAGE; COLON ULCER; COLONOSCOPY; FEMALE; FOLLOW UP; HEMATOCHEZIA; HUMAN; ISCHEMIC COLITIS; LEUKOCYTOSIS; LOWER ABDOMINAL PAIN; NAUSEA AND VOMITING;

EID: 77950802489     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i12.1537     Document Type: Article

References (19)

1. Vedamurthy M. Mesotherapy. Indian J Dermatol Venereol Leprol 2007; 73: 60-62
2. Bray GA, Ryan DH. Drug treatment of the overweight patient. Gastroenterology 2007; 132: 2239-2252
3. Naik M, Potluri R, Almasri E, Arnold GL. Sumatriptanassociated ischemic colitis. Dig Dis Sci 2002; 47: 2015-2016
4. Dowd J, Bailey D, Moussa K, Nair S, Doyle R, CulpepperMorgan JA. Ischemic colitis associated with pseudoephedrine: four cases. Am J Gastroenterol 1999; 94: 2430-2434
5. Halpern A, Mancini MC. Treatment of obesity: an update on anti-obesity medications. Obes Rev 2003; 4: 25-42
6. Yanovski SZ, Yanovski JA. Obesity. N Engl J Med 2002; 346: 591-602
7. Krupski WC, Selzman CH, Whitehill TA. Unusual causes of mesenteric ischemia. Surg Clin North Am 1997; 77: 471-502
8. Hass DJ, Kozuch P, Brandt LJ. Pharmacologically mediated colon ischemia. Am J Gastroenterol 2007; 102: 1765-1780
9. Cole JA, Cook SF, Sands BE, Ajene AN, Miller DP, Walker AM. Occurrence of colon ischemia in relation to irritable bowel syndrome. Am J Gastroenterol 2004; 99: 486-491
10. Hourmand-Ollivier I, Bouin M, Saloux E, Morello R, Rousselot P, Piquet MA, Dao T, Verwaerde JC. Cardiac sources of embolism should be routinely screened in ischemic colitis. Am J Gastroenterol 2003; 98: 1573-1577
11. Collet T, Even C, Bouin M, Lecluse E, Piquet MA, Crampon D, Grollier G, Dao T, Verwaerde JC. Prevalence of electrocardiographic and echocardiographic abnormalities in ambulatory ischemic colitis. Dig Dis Sci 2000; 45: 23-25
12. Koutroubakis IE, Sfiridaki A, Theodoropoulou A, Kouroumalis EA. Role of acquired and hereditary thrombotic risk factors in colon ischemia of ambulatory patients. Gastroenterology 2001; 121: 561-565
13. Theodoropoulou A, Sfiridaki A, Oustamanolakis P, Vardas E, Livadiotaki A, Boumpaki A, Paspatis G, Koutroubakis IE. Genetic risk factors in young patients with ischemic colitis. Clin Gastroenterol Hepatol 2008; 6: 907-911
14. Park SH, Kim DW, Lee MA, Yoo SC, Rhee SC, Koo SH, Seol GH, Cho EY. Effectiveness of mesotherapy on body contouring. Plast Reconstr Surg 2008; 121: 179e-185e
15. Anderson M. The properties of aminophylline. Emerg Nurse 2007; 15: 24-27
16. Kopelman PG. Emerging management strategies for obesity. Int J Obes Relat Metab Disord 1998; 22 Suppl 1: S7-S11; discussion S12, S42
17. Auvichayapat P, Prapochanung M, Tunkamnerdthai O, Sripanidkulchai BO, Auvichayapat N, Thinkhamrop B, Kunhasura S, Wongpratoom S, Sinawat S, Hongprapas P. Effectiveness of green tea on weight reduction in obese Thais: A randomized, controlled trial. Physiol Behav 2008; 93: 486-491
18. Schembre DB, Boynton KK. Appetite-suppressant drugs and primary pulmonary hypertension. N Engl J Med 1997; 336: 510-511; author reply 512-513
19. Comay D, Ramsay J, Irvine EJ. Ischemic colitis after weightloss medication. Can J Gastroenterol 2003; 17: 719-721